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Abstract. The impact of metabolic changes in type 2 diabetes on bone turnover. Safarova Sain Sattar. This article 
carried out analyzes which helps to identify risk factors associated with bone metabolism changes, and to determine 
indicators that are informative in terms of predicting the risk of low-traumatic fractures observed in patients with type 2 
diabetes mellitus. This study revealed some correlation between serum insulin level, bone metabolism markers and bone 
mass density determined at the lumbar DXA in patients with type 2 diabetes mellitus. This suggests that the presence of 
type 2 diabetes in anamnesis aggravated violation of disturbances of bone remodeling, thus contributing to the 
development of osteoporosis. The purpose of this study was to identify complex relationships between the mineral, 
organic component of bone and the risk of fractures under the influence of metabolic changes associated with type 2 
diabetes. This study suggests that obesity and hyperinsulinemia can not be bone-protective factors, this is confirmed by 
the growing body of evidence that points to the importance of measuring bone remodeling markers in combination with 
bone mineral density in assessing and predicting the risk of fractures. Clarification of the role of insulin in assessing 
bone health remains a matter of debate. 
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Реферат. Вплив метаболічних змін при діабеті 2 типу на обмінні процеси в кістці. Сафарова С.С. У 
статті проведено дослідження, що допомагає виявити фактори ризику, пов'язані зі зміною метаболізму 
кісткової тканини, і визначити показники, інформативні щодо прогнозування ризику нізькотравматичних 
переломів, що спостерігаються в пацієнтів з цукровим діабетом 2 типу. У ході цього дослідження виявлена 
певна кореляція між рівнем сироваткового інсуліну, маркерами кісткового метаболізму і щільністю кісткової 
маси, яка визначається при поперековій DXA у пацієнтів з цукровим діабетом 2 типу. Це дозволяє вважати, 
що наявність цукрового діабету 2 типу в анамнезі посилює порушення кісткового ремоделювання, тим самим 
сприяючи розвитку остеопорозу. Мета цього дослідження полягала у виявленні складних взаємозв'язків між 
мінеральним, органічним компонентом кістки і ризиком розвитку переломів під впливом метаболічних змін, 
пов'язаних з діабетом 2 типу. Це дослідження свідчить про те, що ожиріння і гіперінсулінемія не можуть 
бути факторами, що захищають кістку, і це доводить зростаюча кількість доказів, що вказують на важ-
ливість вимірювання маркерів кісткового ремоделювання в поєднанні з мінеральною щільністю кістки при 
оцінці і прогнозуванні ризику переломів. Уточнення ролі інсуліну в оцінці стану кістки, як і раніше, 
залишається предметом дискусій. 
 
Accumulated evidence confirms the connection 
between type 2 diabetes mellitus (DM2) and an 
increased risk of low-traumatic fractures against a 
background of high bone mineral density (BMD). 
Disturbance of metabolic processes in bone tissue in 
patients with diabetes mellitus can be caused by the 
direct effect of insulin deficiency and / or hypergly-
cemia on the bone, the accumulation of final glyca-
tion products in the bone matrix that breaks down 
the bone collagen synthesis, the production of in-
flammatory cytokines, the production of adipokines 
that induce a negative imbalance in bone remodeling 
and a violation of neuromuscular regulation [1]. 
Type 2 diabetes is associated with 1.5–2-fold 
increased odds of bone fracture risk than in a healthy 
population, which deterioration in the quality of 
bone tissue can be a major cause of bone fragility 
and does not depend on the decrease in bone mineral 
density. The data suggest that some indicators may 
be more informative in terms of predicting the risk 
of low-traumatic fractures observed in patients with 
diabetes and that in essence the BMD measurement 
does not reflect the real trend towards the deve-
lopment of bone remodeling disorders in patients 
with type 2 diabetes. This determines the need to 
develop improved methods for assessing bone 
properties to clarify stratification risk criteria. 
The purpose of this study was to identify 
complex relationships between the mineral, organic 
component of bone and the risk of fractures under 
the influence of metabolic changes associated with 
type 2 diabetes. 
MATERIALS AND METHODS  
A transverse study was conducted, in which 137 
patients with diabetes mellitus (85 female, 52 male) 
were included, who had not previously been diagno-
sed with bone metabolism and osteoporosis. The age 
of the examined patients is from 40 to 70 years old 
(58.4±0.9 years). The duration of diabetes was 
8.1±0.7 years. All the subjects had diabetes in 
anamnesis, the body mass index (BMI) in kg/m2 
(30.0±0.3 kg/m2) was calculated. The mean value of 
glycosylated hemoglobin (HbA1c) - 7.5±0.2% of 
blood was determined once. The control group 
consisted of 82 patients (48 women and 34 men, 
55.9±0.9 years) without a history of diabetes. 
Exclusion criteria: persons previously treated for 
osteoporosis or with a history of fracture, as well as 
diseases of the endocrine system, liver and kidneys 
of the non-diabetic nature, with a diabetic nephro-
pathy of the 4-5 stage in anamnesis. 
All patients underwent dual-energy X-ray 
Absorbtiometry (DXA) (Densitometer DXA, 
HOLOGIC, Discovery QDR 4500 A.USA model) of 
the lumbar spine (L1-L4) and the proximal and fe-
moral neck areas. The IASC for WHO criteria 
applied to diagnosis was assessed as osteoporosis 
(T-score ≤ 2.5SD), osteopenia (T-score from -1 to -
2.5 SD) and normal (T-score> -1). 
Parameters of phosphorus-calcium metabolism 
were estimated by the concentration of ionized cal-
cium (iCa) using the cresolphthalein and inorganic 
phosphorus (P) complex method by reducing 
phosphomolybdate in blood serum using a bioche-
mical analyzer "COBAS INTEGRA 400/700/800" 
(Switzerland). The insulin, C-peptide, parathyroid 
hormone (PTH), calcitonin (CT) and vitamin D3 
levels in the blood were evaluated by an enzyme-
binding absorbent method (ELISA) using the Cis bio 
international test kit. The glomerular filtration rate 
(GFR) was calculated by the formula CKD-EPI. To 
assess the resistance to insulin, the HOMA-IR (Ho-
meostasis Model Assessment of Insulin Resistance) 
index was calculated [6]. The state of bone tissue 
formation was judged by the activity of total alkaline 
phosphatase (ALP) and the content of the amino-
terminal propeptide of procollagen type I (PINP) in 
serum. The significance of the C-terminal telopep-
tide of type I collagen (beta-CTx) as a serum bone 
resorption marker using an automatic electro- che-
miluminescence analyzer COBAS e41 (Switzerland), 
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using the "Roch Diagnostics" reagents (Germany) 
was estimated. 
Statistical analysis was carried out using "BioStat 
Pro 6.2.2.0" program. Statistical analysis was done 
using unpaired parametric data analyzed by Mann—
Whitney U test. Spearman's rank correlation was 
calculated to assess the power of connection bet-
ween the parameters. P< 0.05 was considered sta-
tistically significant.  
RESULTS AND DISCUSSION  
Characteristics of subjects and clinical characte-
ristics for the study groups are shown in Table. 
 
Characteristics of subjects, Mean ± mean error (M ± m) and (95% CI) 
Characteristics T2DM, n = 137 Non-DM Controls,  n=82 
Sex (M:F) 52/85 39/43 
Age (years) 58,4±0,56 (57,3-59,6) 55,9±0,87 (54,2-57,7) 
Duration of DM (years) 8,1±0,42 (7,2-8,9) - 
BMI (kg/m 2 ) 30,02±0,31 (29,4-30,6) 28,7±0,37 (27,9-29,5) 
НвА1с, % 7,5±0,16 (7,2-7,8) 4,9±0,06 (4,7-5,0) 
tCa, mg/dL 9,4±0,05 (9,3-9,5) 9,5±0,05 (9,4-9,6) 
iCa, mmol/L 1,07±0,01 (1,04-1,08) 1,13±0,01 (1,11-1,15) 
Inorganic P, mmol/L 5,0±0,08 (4,8-5,2) 5,1±0,09 (4,9-5,2) 
eGFR (mL/min/1,73 m 2) 88,5±1,52 (85,4-91,5) 95,2±1,71 (91,8-98,6) 
PTH, pg/mL 51,7±1,44 (48,8-54,6) 45,1±2,33 (40,2-49,8) 
Vitamin D3, ng/mL 25,1±1,08 (22,9-27,2) 30,41±1,72 (26,95-33,86) 
C-peptide, ng/ dL 4,3±0,26 (3,7-4,8) 3,5±0,15 (3,1-3,8) 
HOMA-IR 8,6±0,52 (7,5-9,6) 2,8±0,18 (2,4-3,1) 
ALP, IU/L 122,2±3,01 (116,2-128,1) 123,5±4,88 (113,8-133,2) 
PINP, ng/mL 42,08±1,15 (39,8-44,3) 47,09±2,14 (42,82-51,35) 
b-CTх, ng/mL 0,495±0,02 (0,456-0,533) 0,424±0,02 (0,383-0,466) 
Spine Т-score (L1-L4) -1,08±0,12 (-1,3; -0,8) -0,73±0,19 (-1,1; -0,3) 
Spine Z- score (L1-L4) -0,03±0,14 (-0,3; 0,2) 0,27±0,18 (-0,08; 0,6) 
Femoral neck T– score -1,12±0,12 (-1,3; -0,8) -0,64±0,18 (-1,0; -0,2) 
Femoral neck Z – score 0,02±0,12 (-0,2; 0,3) 0,22±0,17 (-0,1; 0,5) 
 
According to the analysis of the study results, the 
dynamics of insulinemia in patients with diabetes 
was characterized by an increase in insulin response 
(HOMA IR - 8.6±0.52). The mean values of serum 
Hb1Ac were within the norm: for the whole group of 
examined patients - 7.5±0.16% (7.2-7.8). In patients 
with type 2 diabetes, the serum PTH level was also 
associated with the insulin resistance index, the 
HOMA-IR index, as indicated by the rank cor-
relation coefficient r= -0.273, p=0.01. PTH can af-
fect the release of insulin by the pancreas, acting on 
the metabolism of insulin and glucose. Thus, with an 
increase in the concentration of PTH, an increase in 
the level of glucose in the plasma is observed [3]. 
In type 2 diabetes, the P1NP value was statisti-
cally significantly different from the control group 
(p>0.05). However, we found a trend towards a sta-
tistically significant increase in P1NP in men with a 
duration of DM2 type of less than 10 years com-
pared with women in this group (p<0.05), consistent 
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with the data of a number of authors (Sathyapalan 
T., 2017) and is presumably associated with insulin 
resistance [4]. Thus, the resistance to insulin, inclu-
ding osteoblast-specific receptors for insulin which 
develops against hyperinsulinemia leads to a disrup-
tion in the differentiation of osteoblasts and a dec-
rease in the formation of the trabecular bone. Ano-
ther factor that negatively affects bone remodeling is 
a decrease of blood flow to the bone tissue [5]. 
Conducted correlation analysis in the study 
groups revealed a higher BMI in individuals with a 
low serum b-CTx, which was described earlier and 
in a number of other studies [6]. In patients with 
type 2 diabetes, significant correlations were obser-
ved between b-CTx and BMI (r= -0.163, p=0.04), 
insulin concentration (r= -0.210, p=0.02), C-peptide 
(r= -0.402, p=0.001) and the HOMA-IR index (r= -
0.191, p=0.04). Also, in patients with DM2 with a 
duration of disease up to 10 years, the P1NP level 
was weak, but statistically significantly associated 
with the HOMA-IR index, with a rank correlation 
coefficient r=0.217, p=0.05. Biochemical markers of 
bone remodeling in obesity are lower than in in-
dividuals with normal weight [7], but the difference 
in the values of resorption markers is somewhat 
greater than the difference in the values of the 
formation markers. This results in a higher risk of 
bone fracture associated with obesity due to the fact 
that pro-inflammatory cytokines from visceral fat, 
such as interleukin-6 (IL-6) and tumor necrosis fac-
tor-alpha (TNF-α), increase bone resorption, nega-
tive impact on the IPC [8]. 
Our results showed that the level of HbA1c in 
patients with diabetes has a negative correlation with 
the marker of bone formation P1NP: (r= -0.254, 
p=0.01). The negative association of P1NP with 
HbA1c [9] indicates that the formation of bone 
tissue is disturbed by high blood glucose levels; 
accordingly, people with diabetes with unsatis-
factory glycemic control have a greater risk of low-
traumatic fractures. Studies have shown that P1NP 
values are associated with glucose tolerance and 
insulin secretion [8], although mechanisms are not 
fully understood. 
In patients with DM2, a correlation was found 
between the change in the T-score measured in the 
lumbar spine and C-peptide: r=0.346, p=0.02. In 
addition, a positive relationship between the body 
mass index and bone mineral density, particularly 
pronounced with the duration of the underlying di-
sease of less than 10 years, has been revealed. Thus, 
with DM2, a significant dependence was found bet-
ween the change in the T-score measured in the 
femoral neck and BMI: r=0.310, p=0.02; as well as, 
with the HOMA-IR index: r=0.293, p=0.04. In men 
with DM2, a significant relationship was also found 
between the T-score measured in the L1-L4 and 
BMI regions: r=0.314, p=0.04. The existence of a 
positive connection between BMI and bone mineral 
density is confirmed by the data of other authors 
[10]. This confirms the evidence that the BMD 
determined by DXA is higher in obese people, and 
in part, this is due to the fact that higher BMI and 
soft tissue thickness cause an error in DXA mea-
surements [7]. However, with DM2, there was no 
correlation between the BMI score and the T-score 
of the BMD measured in the neck region of the 
femur, which indicates different sensitivity of 
different sites to metabolic changes, as the cortical 
and spongy bone may react differently to insulin, 
glucose, BMI and parathyroid hormone [6]. In ad-
dition, overweight is associated with a delayed loss of 
bone mass in menopause [9], consistent with a trend 
toward a positive bone balance in women with obesity. 
The smaller values of the BMD measured in the 
L1-L4 region and the decrease in bone metabolism 
from the analysis of bone markers manifested by 
inhibition of bone formation processes - P1NP, may 
be caused by insulin resistance in the early stages of 
DM2 (r=0.255, p=0.02) and insulinopenia at long 
course of DM2, as well as hyperglycaemia [10]. 
However, it is obvious that due to the fact that the 
state of the glycemic profile is a very dynamic 
index, the correlation between the level of HbA1c 
and the decrease in the T-score of the MIC was not 
found, which agrees with the results of a number of 
other authors [7]. When comparing the data of the T-
score of the lumbar spine with the level of b-CTX in 
patients with diabetes, a significant relationship was 
found between these indices (r=-0.231, p=0.02). In 
the study, a link between the Z-criterion of the 
lumbar spine and the level of b-CTX in patients with 
diabetes mellitus was found to show a significant 
relationship between these indices (r= -0.227, 
p=0.02). In women with DM2 in premenopause, 
there was no significant dependence on these para-
meters. However, in a subgroup of postmenomausal 
women with DM2, a reliable relationship was found 
for these parameters (r= -0.302, p=0.04), which 
indicates that the physiological decrease in bone 
mineral density after 45 years should also be taken 
into account. Also, in a subgroup of women, a 
correlation was found between these values accor-
ding to the Z-criterion (r= -0.365, p=0.01), which 
emphasizes the relationship between these indica-
tors, and hence the association with osteoporosis in 
the study group. 
This study is an attempt to indicate the impo-
rtance of serum insulin as a possible marker of bone 
remodeling in patients with diabetes. Also 
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significant is the fact that bone remodeling markers 
were considered as the most informative markers for 
assessing the complex effect of insulin on bone me-
tabolism in modern clinical practice, regardless of 
the type of disturbance of its secretion (meaning the 
stage of hyperinsulinemia / insulin resistance or rela-
tive secretory insufficiency with DM2) [9]. In pa-
tients with type 2 diabetes mellitus, changes in bone 
mineral density were detected only in 16% of cases 
corresponded to osteoporosis and osteopenia was 
noted more often than osteoporosis. Another aspect 
of the problem is related to the fact that in diabetes 
mellitus a higher level of bone resorption markers 
than among people who are not diabetic, but the 
mechanism underlying this process remains not 
completely clear [10]. 
CONCLUSIONS 
In this study, it was found that increased insulin 
resistance and / or hyperinsulinemia can affect the 
anabolic response of bone tissue, adversely affecting 
bone strength. This study suggests that obesity and 
hyperinsulinemia can not be bone-protective factors, 
which is confirmed the growing body of evidence 
that points to the importance of measuring bone 
remodeling markers in combination with bone mi-
neral density in assessing and predicting the risk of 
fractures. Further studies are needed to determine 
the pathophysiological mechanisms by which insulin 
resistance can adversely affect bone metabolism. 
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